LAKELAND, Fla., Feb. 5, 2019 /PRNewswire/ -- WellDyneRx, a full-service, independent Pharmacy Benefit Manager (PBM), entered into an agreement with DaVita Inc. to take over their Medicare Part B Bundled Program. WellDyneRx dispensed their first prescriptions to DaVita patients in November 2018 after a successful transition period. DaVita patients now enjoy the convenience of getting their bundled medications delivered directly to their home.
WellDyneRx was selected because DaVita recognized its experience, technology, prescription service offerings, and committed employees. WellDyneRx assumed responsibility for the entire pharmacy process, including order intake, processing, dispensing, member experience and prior authorizations.
"As a result of this partnership, we will ship over 2 million renal prescriptions within the next year," said Zach Johnson, President of WellDyneRx. "We look forward to extending our expertise to positively impact even more lives."
Patients who receive hemodialysis, home hemodialysis (HHD) and peritoneal dialysis (PD) benefit from WellDyneRx's clinical expertise and commitment to optimizing every interaction they have – no matter how small. From offering evidence-based formularies that promote conscientious, cost-effective prescribing, to driving industry-leading adherence rates through high-touch case management services, WellDyneRx is fully committed to the idea that "Every Little Thing BRINGS BIG OUTCOMES."
"We appreciate WellDyneRx's commitment to service excellence for our patients," said Patrick McKinnon, President of DaVita Rx.
To learn more about how WellDyneRx helps streamline operations and increase revenue, visit www.WellDyneRx.com.
About WellDyneRx, Inc.
WellDyneRx is a full-service, independent Pharmacy Benefit Manager (PBM) that makes the little things matter for its clients, employees, partners, and members. WellDyneRx provides members with access to more than 66,000 retail pharmacies across the U.S. and mail order prescription services with the capacity to fulfill more than 15 million prescriptions per year. The company's offerings include a wholly owned specialty pharmacy (www.USSpecialtyCare.com) that focuses on expensive specialized drugs; a national discount card program; and highly targeted pharmacy programs for Diabetes, Hepatitis C and Opioids to balance optimal clinical outcomes with minimized plan costs.
DaVita Inc., a Fortune 500® company, is the parent company of DaVita Kidney Care and DaVita Medical Group. DaVita Kidney Care is a leading provider of kidney care in the United States, delivering dialysis services to patients with chronic kidney failure and end stage renal disease. DaVita Kidney Care operates or provides administrative services at 2,539 outpatient dialysis centers located in the United States. The company also operated 241 outpatient dialysis centers located in 10 countries outside the United States.